Tech Company Financing Transactions
FemTherapeutics Funding Round
On 5/15/2023, FemTherapeutics raised $1.9 million in funding from 2048 Ventures, Investissement Quebec and SheBoot.
Transaction Overview
Company Name
Announced On
5/15/2023
Transaction Type
Venture Equity
Amount
$1,850,000
Round
Undisclosed
Investors
Proceeds Purpose
The new funds will enable us to further develop our platform and devices, kick off pivotal clinical studies, and expand our team, IP portfolio, and R&D efforts," adds Lalani.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
CLIP C9, Montreal General Hospital, 1650 Cedar Ave, Montreal
Quebec, H3G 1A4
CA
Quebec, H3G 1A4
CA
Phone
Website
Email Address
Overview
FemTherapeutics was founded with a singular mission - to redesign the one-size-fits-all approach to women's health and restore gender equality in medical innovation. Inara Lalani, Negin Ashouri, and Dr. Mihnea Gangal were inspired to conceptualize FemTherapeutics after participating and taking home the top prize in the McGill Surgical Innovation Program. As students shadowing Dr. Gangal at the Notre Dame Hospital at the time, Inara and Negin recognized a high pattern of unnecessary hysterectomy surgeries. Diving into the root of the problem and the failing treatment plans on the market, the three of them honed in on vaginal pessaries as a key area in need of improvement.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/15/2023: Ethernovia venture capital transaction
Next: 5/15/2023: Aibidia venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs